Cannonball Kids' Cancer Foundation Report issue

Foundation Phase 1

Organization Overview

First Clinical Trial
2019
NCT03893487
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Cannonball Kids' Cancer Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Astrocytoma (Phase 1)

Glioblastoma (Phase 1)

Glioma (Phase 1)

Medulloblastoma (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 5